Clinical Trial Update: A Trial of SHR-7787 Injection in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating SHR-7787 injections in patients with advanced solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• SHR-7787 (SHR-7787)

Snippet

Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. | Conditions: Advanced Solid Tumors | Phase 1, Phase 2 | Status: RECRUITING